Protocol # WA25046: A Phase III, Multicentre, Randomized, Parallel-Group, Double Blinded, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults with Primary Progressive Multiple Sclerosis"

Project: Research project

Project Details

StatusFinished
Effective start/end date4/19/124/19/15

Funding

  • PPD Development (WA25046)
  • Genentech, Inc. (WA25046)